Neoplasma
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 39.0% | 0.586 | Q2 | 66.8% |
| 2024 | 2.2 | Q3 | 34.0% | 0.647 | Q2 | 70.9% |
| 2023 | 2.0 | Q3 | 31.7% | 0.588 | Q2 | 70.3% |
| 2022 | 3.0 | Q3 | 43.4% | 0.609 | Q2 | 72.5% |
| 2021 | 3.4 | Q3 | 47.9% | 0.580 | Q2 | 71.8% |
| 2020 | — | — | 0.628 | Q3 | 73.0% | |
| 2019 | — | — | 0.595 | Q3 | 72.4% | |
| 2018 | — | — | 0.584 | Q3 | 69.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0028-2685
ISSN
1338-4317
country
SKcoverage
1957-2025